Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40762887	b-krea	— (—)	85	100	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Gastro-oesophageal reflux disease

6.47

15.92

1.2

—

Functional dyspepsia

10.84

11.95

1.4

1.3

—

Diseases of oesophagus, stomach and duodenum

4.56

10.76

1.2

—

Cough

6.54

9.22

1.2

1.1

—

Other fall from one level to another

10.00

8.63

1.2

—

Diverticular disease of intestine

4.30

7.71

1.2

—

Transport accidents

5.64

7.27

1.1

1.2

—

Other diseases of intestines

3.46

6.38

1.2

—

Abnormalities of heart beat

5.74

6.03

1.3

1.2

—

Substance abuse, excluding more controls

4.54

5.77

1.1

—

Continuous positive airway pressure

15.54

5.76

1.4

1.2

—

Diaphragmatic hernia

4.80

5.49

1.2

—

Substance abuse

4.05

5.18

1.1

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.10

5.11

1.2

—

Mental and behavioural disorders due to psychoactive substance use

3.89

4.89

1.1

1.2

—

Medical observation and evaluation for suspected diseases and conditions

3.90

4.58

1.2

—

Other noninflammatory disorders of uterus, except cervix

5.25

4.38

1.3

1.2

—

Presence of other devices

8.89

4.27

1.5

1.1

—

Other functional intestinal disorders

4.19

4.24

1.3

1.2

—

Benign neoplasms

3.02

4.20

1.3

1.1

—

Fitting and adjustment of other devices

4.09

4.10

1.4

1.2

—

Abnormalities of breathing

2.97

3.98

1.3

1.1

—

Pain in throat and chest

3.06

3.98

1.3

1.1

—

3.90

3.92

1.5

1.1

—

Mental and behavioural disorders due to alcohol

3.82

3.81

1.1

1.2

—

Pedal cyclist injured in noncollision transport accidents

12.01

3.76

1.3

1.0

—

Concussion

3.58

3.70

1.2

—

Parasetamol

3.27

3.68

1.1

1.2

—

Other gastritis (incl. Duodenitis)

7.78

3.55

1.1

1.3

—

Pain in joint

3.44

3.51

1.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3.84

3.51

1.1

1.2

—

Other and unspecified anaemias

3.55

3.45

1.4

1.2

—

Other anaemias

3.54

3.43

1.4

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.09

3.34

1.2

—

Erysipelas

2.97

3.32

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

2.64

3.29

1.2

1.1

—

Undetermined asthma, excluding more controls

8.57

3.26

1.3

—

Headache

2.85

3.26

1.1

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.44

3.24

1.3

1.1

—

Alcohol use disorder, Swedish definition

3.40

3.22

1.1

1.2

—

Obesity due to excess calories

3.57

3.19

1.2

—

Aplastic and other anaemias

3.36

3.19

1.4

1.2

—

Chronic gastritis

6.37

3.18

1.1

1.4

—

2.28

3.15

1.3

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

2.76

3.15

1.2

—

Other soft tissue disorders, not elsewhere classified

2.55

3.14

1.0

1.2

—

Undetermined asthma

7.50

3.05

1.3

—

Anxiety (asthma-related co-morbidities)

3.15

3.02

1.3

1.2

—

Polyarthropathies

2.92

2.99

1.2

—

Benign neoplasm: Stomach

10.01

2.98

1.4

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

10.01

2.98

1.0

1.2

—

Asthma-related infections

2.84

2.93

1.5

1.2

—

Asthma, hospital admission 2, infections

2.84

2.93

1.5

1.2

—

Intracranial trauma

3.09

2.90

1.3

1.2

—

Chronic periodontitis, including avohilmo

2.38

2.89

1.1

1.2

—

Other nutritional deficiencies

2.82

2.89

1.2

—

Asthma (only as main-diagnosis), excluding more controls

2.79

2.89

1.3

1.1

—

Acute upper respiratory infections

2.26

2.88

1.3

1.1

—

Parodontitis

2.37

2.87

1.1

1.2

—

Rheumatism, unspecified

6.67

2.86

1.0

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

6.67

2.86

1.3

1.2

—

Car occupant injured in other and unspecified transport accidents

6.67

2.86

1.0

1.1

—

Parodontitis or operation codes

2.33

2.77

1.1

1.2

—

Benign neoplasms

2.74

2.76

1.3

1.1

—

Coxibs

6.21

2.76

1.3

1.5

—

Parodontitis and operation codes

2.37

2.75

1.1

1.2

—

2.90

2.75

1.1

1.2

—

Polymyalgia rheumatica

8.34

2.75

1.6

1.2

—

Injuries to the neck

5.00

2.72

1.1

—

Haemorrhoids and perianal venous thrombosis

5.00

2.72

1.0

1.2

—

Other diseases of anus and rectum

5.00

2.72

1.4

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.31

2.70

1.3

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

2.70

2.69

1.2

—

Benign neoplasm of other and ill-defined parts of digestive system

6.00

2.69

1.3

—

Other symptoms and signs involving the digestive system and abdomen

6.00

2.69

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

3.01

2.69

1.2

1.1

—

Disorders of sclera, cornea, iris and ciliary body

2.97

2.69

1.0

1.2

—

Gout

4.91

2.65

1.1

1.3

—

Other disorders of ear

2.30

2.64

1.3

1.2

—

Artificial joint operation, meniscal resection

2.30

2.63

1.3

1.2

—

Other specific joint derangements/joint disorders

2.68

2.62

1.3

1.2

—

All anxiety disorders

2.84

2.59

1.3

1.1

—

Irritable bowel syndrome

4.67

2.59

1.1

—

Osteopathies and chondropathies

2.78

2.59

1.5

1.1

—

Acute sinusitis

2.93

2.59

1.2

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

3.04

2.56

1.2

—

Benign neoplasm: Stomach

7.15

2.55

1.4

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.06

2.55

1.1

1.2

—

Persons encountering health services in other circumstances

3.46

2.47

1.1

1.2

—

Ventral hernia

4.38

2.47

1.3

1.2

—

Gout, FINNGEN

4.38

2.47

1.1

1.3

—

Pain, not elsewhere classified

4.38

2.47

1.3

—

ILD medications

2.17

2.47

1.3

1.1

—

Asthma (only as main-diagnosis)

2.51

2.44

1.3

1.1

—

Injuries to the knee and lower leg

2.10

2.41

1.3

1.1

—

2.81

2.41

1.1

1.2

—

Obesity

2.64

2.40

1.2

—

Obesity and other hyperalimentation

2.64

2.39

1.2

—

Symptoms and signs involving the urinary system

2.33

2.39

1.4

1.2

—

Chronic laryngitis and laryngotracheitis

6.25

2.37

1.2

1.0

—

Benign neoplasm: Colon

2.70

2.37

1.2

—

Sleep disorders (combined)

2.18

2.37

1.2

—

Osteoporosis

4.17

2.36

1.6

1.1

—

Voice disturbances

3.64

2.36

1.0

1.1

—

Sleep apnoea

2.22

2.34

1.2

1.1

—

Primary gonarthrosis, bilateral

2.63

2.32

1.5

1.1

—

Opioids

2.22

2.31

1.2

1.1

—

Codeine

2.25

2.29

1.3

1.1

—

Asthma, hospital admissions , main diagnosis only

2.24

2.26

1.4

1.1

—

Benign neoplasm: Colon

2.56

2.26

1.3

1.2

—

Codeine or tramadol medication

2.08

2.24

1.2

—

Gout, strict definition

5.56

2.21

1.2

—

Bacterial intestinal infections, IBD co-morbidities

5.56

2.21

1.2

1.3

—

Neurotic, stress-related and somatoform disorders

2.20

1.2

1.1

—

Excessive, frequent and irregular menstruation

3.34

2.19

1.3

1.1

—

Anxiety disorders

2.19

2.18

1.2

1.1

—

Gout, idiopatic and unspecified

4.29

2.15

1.2

1.4

—

Pedal cyclist injured in transport accident

4.29

2.15

1.3

1.1

—

Myalgia

4.29

2.15

1.2

1.3

—

Migraine with aura

4.29

2.15

1.2

1.1

—

Gonarthrosis, primary, with knee surgery

2.41

2.12

1.4

1.1

—

Oral corticosteroids

2.09

2.12

1.2

1.1

—

Alcohol use disorder, ICD-based

3.20

2.09

1.0

1.2

—

Unspecified acute lower respiratory infection

5.00

2.07

1.2

—

Gout, unspecified

5.00

2.07

1.2

1.4

—

Convulsions, not elsewhere classified

4.94

2.05

1.4

—

Irregular menses

2.92

2.03

1.2

1.1

—

Dentofacial anomalies [including malocclusion]

3.96

2.01

1.2

—

Mouth breathing

3.08

2.01

1.3

1.2

—

Asthma (mode)

2.29

2.00

1.3

1.1

—

Neurological diseases

2.24

1.99

1.2

—

Falls/tendency to fall

2.07

1.98

1.2

1.1

—

Obesity related asthma

3.33

1.96

1.4

1.1

—

Sleep apnoea, including avohilmo

2.05

1.96

1.2

1.1

—

Other bacterial intestinal infections

4.55

1.94

1.2

1.5

—

Other (seronegative) rheumatoid arthritis, wide

4.55

1.94

1.4

1.1

—

Sensorineural hearing loss

2.19

1.93

1.1

1.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

3.75

1.93

1.5

1.3

—

Asthma, including avohilmo

1.94

1.93

1.2

1.1

—

Heart failure and bmi 25plus

2.82

1.91

1.6

1.2

—

Polycystic ovarian syndrome, consortium definition

2.21

1.91

1.3

1.2

—

Heart failure,strict

2.40

1.90

1.5

1.1

—

Other anxiety disorders

2.96

1.90

1.3

1.1

—

Any mental disorder

1.95

1.89

1.2

—

Other intervertebral disc disorders

2.13

1.89

1.2

—

Other joint disorders

2.22

1.87

1.3

1.2

—

Sequelae of injuries, of poisoning and of other consequences of external causes

3.53

1.83

1.2

1.1

—

Hernia

2.02

1.82

1.2

—

Hallux valgus (acquired)

2.90

1.81

1.5

1.2

—

Other heart diseases

2.70

1.81

1.1

—

Any gastric operation

2.27

1.80

1.2

—

GASTRO-related operations

2.27

1.80

1.2

—

Diseases of external ear

3.04

1.79

1.3

1.2

—

Intracranial injury

2.36

1.79

1.3

1.2

—

Symptoms and signs involving speech and voice

2.76

1.79

1.0

1.2

—

Other benign neoplasms of skin

2.76

1.79

1.3

1.2

—

Asthma (diagnoses ohter than nonallergic)

2.01

1.77

1.4

1.1

—

Menorrhagia

2.95

1.77

1.4

1.1

—

Psychiatric diseases

1.93

1.76

1.2

—

STROKE

2.31

1.75

1.1

1.2

—

Endometriosis ASRM stages 3,4

3.33

1.74

1.3

1.2

—

Other enthesopathies

3.33

1.74

1.2

—

Preterm labour and delivery

3.33

1.74

1.5

1.0

—

Deviated nasal septum

3.33

1.74

1.0

1.2

—

Other diseases of upper respiratory tract

1.94

1.73

1.2

—

Conductive and sensorineural hearing loss

2.08

1.73

1.1

1.2

—

Diseases of liver

2.92

1.72

1.0

1.2

—

Chronic sinusitis

2.67

1.72

1.3

1.2

—

All-cause Heart Failure

2.28

1.71

1.5

1.1

—

Low back pain

2.18

1.71

1.1

1.2

—

Heart failure, strict

2.27

1.71

1.5

1.1

—

Shoulder lesions

2.14

1.69

1.1

1.2

—

Gastrointestinal diseases

3.19

1.69

1.1

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.95

1.69

1.3

1.1

—

Other hearing loss

3.78

1.68

1.6

1.1

—

Allergic asthma (mode), excluding more controls

3.78

1.68

1.4

1.2

—

Acetic acid derivatives and related substances

4.34

1.67

1.2

1.5

—

Fracture of rib(s), sternum and thoracic spine

3.16

1.66

1.0

1.3

—

Other systemic involvement of connective tissue (FG)

3.14

1.65

1.5

1.3

—

Depression or dysthymia

2.20

1.64

1.2

1.3

—

Chronic diseases of tonsils and adenoids

2.17

1.62

1.2

1.1

—

Exposure to other specified factors

2.16

1.62

1.6

1.1

—

Superficial injury of lower leg

3.57

1.61

1.2

1.1

—

Postmenopausal bleeding

2.96

1.60

1.0

1.1

—

Recurrent or chronic depression

2.81

1.59

1.3

—

Allergic asthma (mode)

3.51

1.58

1.4

1.1

—

Other systemic involvement of connective tissue

3.00

1.58

1.5

1.2

—

Urticaria and erythema

2.69

1.58

1.4

1.2

—

Internal derangement of knee

2.99

1.57

1.0

1.2

—

Other arthrosis

2.38

1.57

1.2

—

Asthma, excluding more controls

2.17

1.56

1.3

1.1

—

Heart failure and antihypertensive medication

3.67

1.55

1.2

1.0

—

Asthma

2.09

1.55

1.4

1.1

—

Asthma, unspecified (mode)

2.33

1.54

1.4

1.1

—

Injuries to the thorax

2.42

1.53

1.1

1.3

—

Fracture of forearm

2.28

1.52

1.1

—

Endometriosis

2.78

1.52

1.4

1.1

—

Salpingitis and oophoritis

3.33

1.52

1.0

1.1

—

Cervicalgia

3.33

1.52

1.4

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.10

1.51

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.96

1.51

1.4

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.49

1.50

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.85

1.50

1.0

1.1

—

Gonarthrosis

2.15

1.45

1.4

1.2

—

Visual disturbances and blindness

2.37

1.45

1.4

1.1

—

Systemic connective tissue disorders

2.50

1.45

1.4

1.2

—

Chronic lower respiratory diseases

1.77

1.45

1.3

1.1

—

Fall on same level

1.80

1.45

1.3

1.1

—

Asthma, unspecified (mode), excluding more controls

2.36

1.44

1.3

1.1

—

Lyme disease

3.13

1.44

1.0

1.1

—

Other spirochaetal diseases

3.13

1.44

1.0

1.1

—

Other noninfective gastroenteritis and colitis

3.12

1.43

1.2

1.3

—

Other reaction to severe stress, and adjustment disorders

2.73

1.43

1.3

1.1

—

Coxarthrosis

2.35

1.42

1.2

—

Abdominal and pelvic pain

1.92

1.42

1.4

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.91

1.41

1.3

1.1

—

Inflammatory diseases of female pelvic organs

2.06

1.40

1.2

—

Asthma/COPD (KELA code 203)

1.85

1.39

1.4

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.96

1.38

1.4

1.2

—

Inflammatory bowel disease treatment related agents

1.79

1.37

1.3

1.1

—

Anxiety disorders, excluding more controls

1.93

1.36

1.3

1.2

—

Varicose veins

1.96

1.36

1.1

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2.94

1.36

1.0

1.1

—

Disorders of vestibular function (Vertigo)

2.18

1.35

1.1

1.2

—

Epilepsy

2.93

1.35

1.2

1.4

—

Conduction disorders

2.63

1.35

1.7

1.2

—

Myocardial infarction, strict

2.19

1.34

1.1

1.3

—

Other diseases of urinary system

1.80

1.32

1.1

1.2

—

Keratitis

2.50

1.30

1.0

1.3

—

Asthma-related pneumonia

2.50

1.30

1.7

1.2

—

Asthma, hospital admissions 3, pneumonia

2.50

1.30

1.7

1.2

—

Asthma-related pneumonia or sepsis

2.50

1.30

1.7

1.2

—

Cardiovascular diseases

2.42

1.29

1.1

—

Soft tissue disorders related to use, overuse and pressure

2.78

1.28

1.2

1.3

—

Urticaria

2.78

1.28

1.4

1.1

—

Finngen Rheumatological endpoints

1.86

1.28

1.1

1.2

—

Rheumatoid arthritis

2.48

1.28

1.3

1.2

—

First line medication for Crohn's disease

1.78

1.27

1.4

1.1

—

Other benign neoplasms of skin

2.31

1.27

1.3

1.2

—

Cerebrovascular diseases (FINNGEN)

2.53

1.27

1.0

1.1

—

Autoimmune diseases related-to ILD

1.84

1.26

1.1

1.2

—

Coxarthrosis [arthrosis of hip](FG)

2.13

1.26

1.2

—

External causes of morbidity and mortality

2.12

1.26

1.2

1.1

—

Episodal and paroxysmal disorders

1.78

1.25

1.1

1.2

—

Gingivitis and periodontal diseases

1.90

1.24

1.1

1.3

—

Hernia of abdominal wall

2.22

1.24

1.3

1.2

—

Complications of surgical and medical care, not elsewhere classified

1.77

1.23

1.3

1.2

—

Oedema, not elsewhere classified

2.39

1.23

1.3

1.2

—

Disorders of the thyroid gland

1.77

1.23

1.0

1.3

—

Diseases of oral cavity, salivary glands and jaws

1.89

1.22

1.1

1.3

—

Fall on and from stairs and steps

2.63

1.21

1.4

1.2

—

Colonic or urogenital fistula

2.63

1.21

1.4

1.2

—

Diseases of pulp and periapical tissues

2.63

1.21

1.2

1.3

—

Constipation

1.79

1.21

1.3

1.2

—

Accidents

1.92

1.17

1.2

1.1

—

Other external causes of accidental injury

1.92

1.17

1.2

1.1

—

Pain (limb, back, neck, head abdominally)

2.04

1.16

1.2

—

Injuries to the elbow and forearm

1.87

1.15

1.3

1.2

—

Other heart diseases, wide

1.81

1.14

1.1

—

Injuries to the hip and thigh

2.03

1.13

1.6

1.2

—

Migraine

2.38

1.13

1.1

1.2

—

Other disorders of urethra and urinary system

1.87

1.12

1.2

1.1

—

Myocardial infarction, without ST-elevation

2.31

1.11

1.1

1.3

—

General symptoms and signs

1.70

1.10

1.1

1.2

—

Rheumatoid arthritis, including avohilmo

2.26

1.10

1.3

1.2

—

Temporomandibular joint disorders, including avohilmo

2.26

1.10

1.3

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.97

1.10

1.4

1.2

—

Dyspnoea

1.76

1.09

1.4

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.38

1.09

1.2

1.0

—

Other acute lower respiratory infections

1.96

1.08

1.3

1.2

—

Papulosquamous disorders

2.19

1.08

1.0

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.22

1.07

1.0

1.2

—

Complications of medical and surgical care

1.81

1.06

1.3

1.2

—

Heart failure, not strict

1.79

1.06

1.2

1.1

—

Bronchitis

1.64

1.03

1.4

1.1

—

Fall on same level involving ice and snow

1.96

1.03

1.2

—

Depression

1.69

1.03

1.3

1.2

—

Visual disturbances

2.06

1.02

1.6

1.1

—

Selective serotonin reuptake inhibitors

1.68

1.02

1.1

1.2

—

Other pulmonary diagnosis

1.81

1.02

1.2

1.1

—

Disorders of lacrimal system

2.00

1.00

1.4

1.2

—

N06DA Anticholinesterases

0.00

0.99

0.0

1.3

—

Use of anticholinesterases

0.00

0.99

0.0

1.3

—

Unspecified fall

1.98

0.99

1.3

1.2

—

Dorsopathies

1.67

0.98

1.1

1.2

—

Psoriasis

2.17

0.98

1.0

1.1

—

Soft tissue disorders

1.69

0.98

1.1

1.2

—

Disorders of breast

1.81

0.97

1.3

1.2

—

Diseases of inner ear

1.80

0.96

1.1

1.2

—

Artrosis, including avohilmo

1.71

0.95

1.3

1.1

—

Pain in limb

1.81

0.94

1.0

1.2

—

Hyperlipidaemia, other/unspecified

1.89

0.93

1.3

—

Tramadol

1.75

0.92

1.3

1.1

—

Other disorders of skin and subcutaneous tissue

1.77

0.92

1.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.81

0.91

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.69

0.90

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.92

0.89

1.3

1.1

—

Other headache syndromes

2.07

0.89

1.2

—

Persons encountering health services for examination and investigation

1.91

0.88

1.1

1.2

—

Unspecified haematuria

2.06

0.88

1.3

1.1

—

Complications of labour and delivery

1.86

0.88

1.4

1.0

—

Myocardial infarction

1.85

0.87

1.1

1.3

—

Cerebrovascular diseases

1.66

0.86

1.1

1.2

—

Unstable angina pectoris

1.99

0.86

1.2

1.3

—

Presence of cardiac and vascular implants and grafts

1.97

0.85

1.3

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.93

0.84

1.2

1.3

—

Presence of other functional implants

1.77

0.83

1.4

1.1

—

Meniscus derangement

1.77

0.83

1.1

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.74

0.82

1.0

1.2

—

Later onset COPD

0.00

0.80

0.0

1.3

—

Arthropathies

1.70

0.80

1.3

1.2

—

COPD, hospital admission 2, with asthma infections

0.00

0.80

0.0

1.2

—

Diseases of the ear and mastoid process

1.54

0.80

1.4

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.59

0.79

1.0

1.2

—

Injuries to the head

1.53

0.78

1.3

1.2

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.77

0.0

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.96

0.76

1.3

1.0

—

Excluding asthma or asthma-COPD overlap

1.67

0.76

1.2

1.1

—

COPD differential diagnosis

1.67

0.76

1.2

1.1

—

ILD differential diagnosis

1.67

0.76

1.2

1.1

—

Complications of procedures, not elsewhere classified

1.62

0.76

1.2

—

Noninfective enteritis and colitis

1.76

0.76

1.2

—

Non-ischemic cardiomyopathy

2.16

0.76

1.6

1.2

—

Injuries to the ankle and foot

1.71

0.75

1.3

1.1

—

Vasomotor and allergic rhinitis

2.14

0.75

1.4

1.0

—

Hypertensive diseases (excluding secondary)

1.85

0.74

1.1

—

Other arrhythmias

1.64

0.73

1.2

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.70

0.73

1.6

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.58

0.73

1.0

1.3

—

Female genital prolapse

2.06

0.73

1.2

1.1

—

Valvular heart disease excluding rheumatic fever

1.83

0.73

1.1

—

Non-rheumatic valve diseases

1.82

0.73

1.1

—

Syncope and collapse

1.82

0.73

1.6

1.1

—

Other and unspecified iron deficiency

2.00

0.72

1.0

1.3

—

Disorders of synovium and tendon

1.80

0.72

1.1

1.3

—

Arthrosis

1.72

0.71

1.3

1.2

—

Abnormal findings on diagnostic imaging of lung

1.75

0.71

1.1

1.2

—

Nontoxic goitre/thyroid nodule

1.92

0.70

1.0

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.92

0.70

1.0

1.2

—

Parodontitis or/and operation codes

1.70

0.70

1.1

1.2

—

Sequelae of cerebrovascular disease

1.91

0.70

1.2

1.3

—

Cardiac arrhythmias

1.71

0.70

1.1

—

Hypothyroidism, other/unspecified

1.56

0.69

1.0

1.3

—

Infections of the skin and subcutaneous tissue

1.70

0.69

1.1

1.2

—

Acute tubulo-interstitial nephritis

1.53

0.68

1.1

1.2

—

Mood [affective] disorders

1.49

0.68

1.3

1.2

—

Other disorders of eyelid

1.65

0.67

1.4

1.2

—

Hypothyroidism, strict autoimmune

1.62

0.67

1.0

1.3

—

Mood disorders

1.49

0.67

1.3

1.2

—

COPD/asthma/ILD related infections

1.48

0.66

1.3

1.1

—

COPD/asthma related infections

1.48

0.66

1.3

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.79

0.66

1.0

1.2

—

Diseases of the skin and subcutaneous tissue

1.53

0.65

1.3

1.2

—

Other dorsopathies, not elsewhere classified

1.51

0.63

1.1

1.2

—

Mood disorders, excluding more controls

1.52

0.63

1.3

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.62

0.0

1.2

—

Other obstetric conditions, not elsewhere classified

0.00

0.62

0.0

1.2

—

Other abnormal products of conception

0.00

0.61

0.0

1.2

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.2

—

Suppurative and unspecified otitis media

0.00

0.60

0.0

1.1

—

Speech therapy

0.00

0.60

0.0

1.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.57

0.60

1.3

1.2

—

Gestational [pregnancy-induced] hypertension

0.00

0.59

0.0

1.1

—

Sub-endpoint used in defining T1D endpoints

0.00

0.59

0.0

1.3

—

Examination and observation for other reasons

1.74

0.58

1.7

1.2

—

Lumbar disc prolapse

1.51

0.58

1.0

1.2

—

Type 2 diabetes, strict (exclude DM1)

1.47

0.58

1.2

—

Other bacterial diseases

1.47

0.57

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

1.67

0.56

1.5

1.2

—

Other antidepressants

1.46

0.56

1.1

1.2

—

Major coronary heart disease event excluding revascularizations

1.55

0.56

1.1

1.3

—

Persons encountering health services in other circumstances, wide

1.40

0.56

1.2

—

Angina pectoris

1.52

0.55

1.3

1.2

—

1.61

0.55

1.5

1.2

—

Dental caries 2, only avohilmo

1.51

0.54

1.1

1.2

—

Type 2 diabetes, definitions combined

1.44

0.54

1.2

—

Diseases of the digestive system

1.58

0.54

1.3

1.2

—

Dental caries 2

1.47

0.54

1.1

1.2

—

Lower back pain or/and sciatica

1.43

0.53

1.1

1.2

—

Disorders of eyelid, lacrimal system and orbit

1.47

0.53

1.2

—

Coxarthrosis, primary

1.45

0.53

1.2

—

Dermatitis and eczema

1.40

0.53

1.1

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

1.43

0.52

1.2

—

Hard cardiovascular diseases

1.50

0.52

1.0

1.3

—

Dizziness and giddiness

1.49

0.52

1.4

1.1

—

Renal tubulo-interstitial diseases

1.46

0.52

1.1

1.2

—

Other and unspecified dermatitis

1.50

0.51

1.2

1.3

—

Dorsalgia

1.44

0.49

1.2

—

Type 2 diabetes

1.41

0.49

1.2

—

Spondylopathies

1.48

0.49

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.40

0.49

1.3

1.2

—

Triptan medication for migraine, single purchase ok

1.50

0.48

1.2

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.50

0.48

1.2

1.1

—

Diabetes, varying definitions

1.39

0.47

1.2

—

Diabetes mellitus

1.39

0.47

1.2

—

Spondylosis

1.46

0.47

1.4

1.3

—

Gonarthrosis,primary

1.41

0.47

1.3

1.2

—

Autoimmune diseases

1.37

0.45

1.1

1.2

—

Implicit Sepsis

1.47

0.45

1.2

—

Transient ischemic attack

1.38

0.44

1.1

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.39

0.44

1.1

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.60

0.42

1.0

1.3

—

Delivery, wide proxy

1.56

0.42

1.0

1.2

—

Iron deficiency anaemia

1.55

0.42

1.0

1.3

—

Alzheimer’s disease, wide definition

0.00

0.41

0.0

1.4

—

Long labour

0.00

0.41

0.0

1.0

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Type 1 diabetes, wide definition

0.00

0.41

0.0

1.3

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.41

0.0

1.1

—

Type 1 diabetes

0.00

0.40

0.0

1.2

—

Actinic keratosis

1.48

0.40

1.2

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.2

—

Diseases of the musculoskeletal system and connective tissue

1.48

0.40

1.2

1.3

—

Dental caries 2 and operation codes

1.32

0.40

1.1

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1.33

0.40

1.0

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.40

0.0

1.1

—

Disorders of skin appendages

1.43

0.39

1.0

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.43

0.39

1.2

1.3

—

Mycoses

0.00

0.39

0.0

1.1

—

Conjunctivitis (acute, non atopic)

0.00

0.39

0.0

1.3

—

Major coronary heart disease event

1.42

0.38

1.1

1.3

—

Other neurological diseases

1.41

0.38

1.2

—

Hypertension, essential

1.43

0.38

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.35

0.37

1.2

—

Statin medication

0.62

0.37

1.2

—

Hypertensive diseases

1.41

0.37

1.1

—

Hypertension

1.41

0.37

1.1

—

Atopic dermatitis

1.46

0.36

1.0

1.1

—

Fracture of lower leg, including ankle

1.46

0.36

1.2

—

Triptan medication for migraine, min. 3 purchases

1.35

0.34

1.2

1.1

—

Nutritional anaemias

1.36

0.34

1.0

1.2

—

Cholelithiasis

0.67

0.33

1.5

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.32

0.33

1.2

—

Injuries to the wrist and hand

1.32

0.32

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

0.71

0.32

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

0.71

0.32

1.1

1.2

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

0.71

0.32

1.1

1.2

—

Malignant neoplasm

0.70

0.32

1.1

1.2

—

Endocrine, nutritional and metabolic diseases

1.38

0.32

1.1

1.2

—

Leiomyoma of uterus

1.31

0.31

1.3

1.2

—

Appendectomy

1.32

0.30

1.0

1.2

—

Dermatitis

1.32

0.30

1.1

1.2

—

Rotator cuff syndrome

1.30

0.30

1.3

1.2

—

Used for control exclusion in common control thyroid runs

1.29

0.29

1.2

1.3

—

Autoimmune diseases excluding thyroid diseases

1.29

0.29

1.2

—

Stroke, including SAH

1.26

0.28

1.1

1.2

—

Medical abortion

0.70

0.27

1.0

1.3

—

Injuries to the shoulder and upper arm

1.31

0.26

1.2

—

Pure hypercholesterolaemia

0.66

0.26

1.0

1.2

—

Conjunctivitis

0.67

0.26

1.0

1.2

—

Ischemic heart diseases

1.22

0.25

1.1

1.2

—

Ischaemic heart disease, wide definition

1.22

0.25

1.1

1.2

—

Leiomyoma of uterus

1.19

0.25

1.2

—

1.28

0.24

1.3

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.28

0.24

1.3

1.1

—

Disorders of conjunctiva

0.72

0.24

1.0

1.2

—

Peripheral artery disease

1.34

0.23

1.2

—

Influenza and pneumonia

1.24

0.23

1.2

1.1

—

Antihypertensive medication - note that there are other indications

1.30

0.23

1.2

1.0

—

Cholelithiasis, broad definition with cholecystitis

0.76

0.23

1.4

1.2

—

Open wound of head

1.26

0.22

1.0

1.2

—

Other cataract

1.25

0.22

1.2

1.1

—

Certain infectious and parasitic diseases

1.25

0.22

1.1

1.2

—

Single spontaneous delivery

1.21

0.22

1.0

1.2

—

Delivery

1.20

0.22

1.0

1.2

—

Coronary revascularization (ANGIO or CABG)

1.20

0.22

1.2

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.21

0.0

1.1

—

Undefined dementia

0.00

0.21

0.0

1.6

—

Malignant neoplasm of bronchus and lung

0.00

0.21

0.0

1.2

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.21

0.0

1.1

—

Adenomyosis (Endometriosis of uterus)

0.00

0.21

0.0

1.1

—

Retinal breaks without detachment

0.00

0.21

0.0

1.1

—

Non-small cell lung cancer

0.00

0.21

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Exclusions for E4_PCOS_BROAD

0.00

0.21

0.0

1.1

—

DVT of lower extremities

0.00

0.21

0.0

1.3

—

5-aminosalicylic acid

0.00

0.21

0.0

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.21

0.0

1.3

—

Unspecified dementia

0.00

0.21

0.0

1.5

—

Hypotension

0.00

0.21

0.0

1.4

—

Use of rivastigmine

0.00

0.21

0.0

1.5

—

Diabetic nephropathy, excluding more controls

0.00

0.21

0.0

1.3

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.21

0.0

1.2

—

Persistent mood disorders

0.00

0.21

0.0

1.1

—

Other CVD

0.00

0.21

0.0

1.4

—

Medical treatment for female infertility

0.00

0.21

0.0

1.2

—

Pneumonia, organism unspecified

1.24

0.20

1.5

1.1

—

Other diseases of hard tissues of teeth

1.28

0.20

1.2

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

0.20

0.0

1.1

—

Later onset COPD, excluding more controls

0.00

0.20

0.0

1.3

—

Use of donepezil

0.00

0.20

0.0

1.5

—

Use of hypnotics and sedatives

0.78

0.20

1.2

—

Spinal stenosis

1.27

0.20

1.2

1.3

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.20

0.0

1.3

—

Alzheimer’s disease (Late onset)

0.00

0.20

0.0

1.4

—

Lung cancer and mesothelioma

0.00

0.20

0.0

1.3

—

Acute suppurative otitis media

0.00

0.20

0.0

1.1

—

malignant neoplasm of female genital organs

0.00

0.20

0.0

1.3

—

Tinnitus

0.00

0.20

0.0

1.0

—

IBD patients in KELA-register

0.00

0.20

0.0

1.1

—

Effects of foreign body entering through natural orifice

0.00

0.20

0.0

1.1

—

Diabetic nephropathy

0.00

0.20

0.0

1.3

—

Dental caries 3 and operation codes

1.23

0.20

1.3

1.2

—

Intestinal infectious diseases

1.22

0.18

1.2

—

Neoplasms

1.17

0.18

1.1

—

Glaucoma

1.20

0.18

1.6

1.2

—

Disorders of lens

1.16

0.18

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.20

0.17

1.3

1.1

—

Other (not insulin) diabetes medications

1.21

0.17

1.3

1.2

—

Carpal tunnel syndrome

1.18

0.16

1.6

1.2

—

Pregnancy with abortive outcome

0.78

0.16

1.0

1.3

—

Type 2 diabetes, wide definition

1.11

0.16

1.3

1.2

—

Diseases of the eye and adnexa

1.13

0.15

1.2

1.1

—

Disorders of choroid and retina

1.13

0.15

1.2

—

All pneumoniae

1.18

0.15

1.3

1.1

—

Any event in cancer register

0.82

0.14

1.1

1.2

—

Diabetes medication

1.18

0.14

1.3

1.2

—

Biguanides

1.17

0.12

1.3

1.2

—

Injury, poisoning and certain other consequences of external causes

1.14

0.10

1.2

1.1

—

Emergency coronary revascularization (for ACS)

1.12

0.10

1.2

—

Coxarthrosis, primary, with hip surgery

1.13

0.10

1.4

1.2

—

Bacterial infection, other or unspecified

1.10

0.09

1.4

1.2

—

Insulin, intermediate and long-acting

1.09

0.09

1.4

1.2

—

Dental caries 3, only avohilmo

1.16

0.09

1.3

1.2

—

Dental caries 3

1.16

0.09

1.3

1.2

—

Genitourinary diseases

1.04

0.09

1.0

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

1.06

0.09

1.4

1.1

—

Senile cataract

1.09

0.09

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

1.11

0.09

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.09

0.09

1.2

—

Acute appendicitis

1.09

0.08

1.2

—

Reimbursement for rheumatic diseases

1.07

0.08

1.0

1.2

—

Diseases of the respiratory system

0.78

0.08

1.2

1.1

—

Stroke, excluding SAH

1.04

0.08

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1.03

0.08

1.3

1.2

—

Basal cell carcinoma, including avohilmo

0.82

0.08

1.4

1.2

—

Coronary atherosclerosis

1.03

0.08

1.1

1.2

—

Dental caries 2 and operation codes, only avohilmo

1.08

0.07

1.1

1.2

—

Dental caries 1, only avohilmo

0.85

0.07

1.1

1.2

—

Dental caries, including avohilmo

0.85

0.07

1.1

1.2

—

Dental caries 1

0.85

0.07

1.1

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

1.03

0.07

1.1

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.12

0.07

1.4

1.1

—

Benzodiazepine use

1.12

0.06

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1.09

0.03

1.3

1.2

—

Nerve, nerve root and plexus disorders

1.08

0.03

1.4

1.1

—

Dental pulpitis 1, only avohilmo

0.93

0.03

1.3

1.2

—

Dental pulpitis 4, only avohilmo

0.94

0.01

1.3

1.2

—

Dental caries 1 and operation codes

1.07

0.00

1.3

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.00

0.00

1.3

1.2

—

Dental pulpitis 4

0.98

0.00

1.3

1.2

—

Dental pulpitis 1

0.99

0.00

1.3

1.2

—

Metabolic disorders

1.04

0.00

1.1

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

0.98

0.00

1.3

1.2

—

Persons encountering health services for specific procedures and health care

1.00

0.00

1.4

1.1

—

Exposure to unspecified factor

1.05

0.00

1.2

—

Single delivery by caesarean section

0.00

0.0

1.2

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.2

—

Degenerative macular diseases

0.00

0.0

1.4

—

Crohn disease

0.00

0.0

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.88

0.00

1.0

1.2

—

Speech disturbances, not elsewhere classified

0.00

0.0

1.2

—

Allergic conjunctivitis

0.95

0.00

1.0

1.2

—

Melanocytic naevi of trunk

0.00

0.0

1.0

—

Non-follicular lymphoma

0.00

0.0

1.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

0.98

0.00

1.3

1.2

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.88

0.00

1.0

1.2

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.0

1.2

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.0

1.1

—

Eustachian salpingitis and obstruction

0.00

0.0

1.2

—

Memory loss

0.00

0.0

1.4

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.0

1.2

—

Other pleural conditions

0.00

0.0

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.96

0.00

1.0

1.2

—

Appendicitis, broad definition

0.96

0.00

1.2

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

0.0

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

0.0

1.3

—

Puerperal sepsis

0.00

0.0

1.1

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Other obstructed labour

0.00

0.0

1.0

—

Trigger finger

0.00

0.0

1.1

—

Multiple delivery

0.00

0.0

1.2

—

Glomerular diseases

0.00

0.0

1.1

—

Redundant prepuce, phimosis and paraphimosis

0.00

0.0

1.1

—

Nephropathy related operations

0.00

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.0

1.0

—

Other retinal disorders

0.91

0.00

1.3

1.2

—

Intracerebral haemorrhage

0.00

0.0

1.6

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Female infertility, tubal origin

0.00

0.0

1.2

—

Other diseases of gallbladder

0.00

0.0

1.2

—

Diseases of appendix

0.96

0.00

1.2

—

Dental pulpitis 2, only avohilmo

0.97

0.00

1.3

1.2

—

Enlarged lymph nodes

0.00

0.0

1.3

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

0.86

0.00

1.4

1.2

—

Other benign neoplasms of uterus

0.00

0.0

1.2

—

Injury of eye and orbit

0.00

0.0

1.0

—

Use of galantamine

0.00

0.0

1.2

—

Malignant neoplasm of corpus uteri

0.00

0.0

1.1

—

Disorders of vitreous body and globe

0.96

0.00

1.4

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

0.0

1.2

—

Candidiasis

0.00

0.0

1.3

—

Other maternal disorders predominantly related to pregnancy

0.98

0.00

1.2

1.1

—

Other diseases of biliary tract

0.00

0.0

1.2

—

Bronchitis, not specified as acute or chronic

0.00

0.0

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.0

1.1

—

Disorders of vitreous body

1.00

0.00

1.4

1.2

—

Dental operations, only avohilmo

0.96

0.00

1.2

1.3

—

Bell's palsy

0.00

0.0

1.1

—

Insulin medication

1.02

0.00

1.4

1.2

—

Diseases of arteries, arterioles and capillaries

0.90

0.00

1.2

—

Fibromyalgia

0.00

0.0

1.3

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Insulin, fast-acting (human)

0.00

0.0

1.2

—

Dental pulpitis 2

1.00

0.00

1.3

1.2

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Fentanyl

0.00

0.0

1.5

—

Malignant neoplasm of skin

0.89

0.00

1.0

1.2

—

Cystitis

0.96

0.00

1.3

1.2

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Disorders of muscles

0.00

0.0

1.4

—

Dental operations

1.03

0.00

1.2

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Bleeding

1.00

0.00

1.3

1.2

—

ILD medications: immunosuppressive drugs

1.02

0.00

1.4

1.1

—

Thoracic aortic aneurysm

0.00

0.0

1.1

—

Other keratitis

0.00

0.0

1.0

—

Vascular dementia

0.00

0.0

1.7

—

Diabetic neuropathy

0.00

0.0

1.3

—

Normotensive glaucoma

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.2

—

Viral pneumonia

0.00

0.0

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.00

0.00

1.4

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.0

1.1

—

Pleural effusion

0.00

0.0

1.2

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Viral and other specified intestinal infections

0.00

0.0

1.2

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

0.86

0.00

1.4

1.2

—

Lesion of plantar nerve

0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

0.0

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

0.93

0.00

1.3

1.2

—

Mucosal proctocolitis

0.00

0.0

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

0.91

0.00

1.2

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Carcinoma in situ of skin

0.00

0.0

1.2

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.0

1.0

—

Lesion of sciatic nerve

0.00

0.0

1.2

—

Dialysis, with operation codes

0.00

0.0

1.0

—

Carcinoma in situ of skin

0.00

0.0

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

0.0

1.4

—

Other benign neoplasms of uterus

0.00

0.0

1.2

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.2

—

Squamous cell neoplasms and carcinomas of the skin

0.00

0.0

1.4

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.0

1.0

—

Labour and delivery complicated by fetal stress [distress]

0.00

0.0

1.0

—

Pleural plaque

0.00

0.0

1.2

—

Malignant neoplasm of rectum

0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

0.0

1.2

—

Retinal detachment with retinal break

0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

0.0

1.3

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

0.0

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Malignant neoplasm of breast

0.96

0.00

1.2

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.88

0.00

1.0

1.2

—

Malignant neoplasm of breast, HER2-negative

0.98

0.00

1.2

—

Tuberculosis, wide

0.00

0.0

1.2

—

Basal cell carcinoma

0.87

0.00

1.4

1.2

—

Transient global amnesia

0.00

0.0

1.3

—

Seborrhoeic dermatitis

0.00

0.0

1.0

—

Any reimbursement code in KELA

1.00

0.00

1.2

1.0

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Plantar fascial fibromatosis

0.00

0.0

1.2

—

Haemangioma, any site

0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

0.0

1.4

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

Dermatophytosis

0.00

0.0

1.0

—

Foreign body on external eye

0.00

0.0

1.0

—

Melanocytic naevi of trunk

0.00

0.0

1.0

—

Abnormal spermatozoa

0.00

0.0

1.2

—

Abnormal involuntary movements

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Creatinine [Moles/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS